戻る Agenda
SESSION 2: SIGNAL MANAGEMENT – DETECTION, TRIAGE, EVALUATION, FURTHER ACTION (1)
Session Chair(s)
Philip Jones
Disease Area Cluster Lead in Safety Surveillance and Risk Management
Pfizer Ltd., United Kingdom
Signal Management is one of the key pharmacovigilance processes; in this session we will review its position relative to other key processes. The different steps and quality requirements in the process will be explained, with the goal of clarifying the need for IT tools and resources for implementation in various contexts. Participants will work on real life examples in small groups.
Speaker(s)
SIGNAL MANAGEMENT – DETECTION, TRIAGE, EVALUATION, FURTHER ACTION
Philip Jones
Pfizer Ltd., United Kingdom
Disease Area Cluster Lead in Safety Surveillance and Risk Management